Robert Spiegel
2014
In 2014, Robert Spiegel earned a total compensation of $4.4M as Chief Medical Officer at PTC Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $231,000 |
|---|---|
| Option Awards | $3,816,000 |
| Salary | $329,340 |
| Other | $35,005 |
| Total | $4,411,345 |
Spiegel received $3.8M in option awards, accounting for 87% of the total pay in 2014.
Spiegel also received $231K in non-equity incentive plan, $329.3K in salary and $35K in other compensation.
Rankings
In 2014, Robert Spiegel's compensation ranked 1,877th out of 13,032 executives tracked by ExecPay. In other words, Spiegel earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,877 out of 13,032 | 86th |
Division Manufacturing | 664 out of 4,966 | 87th |
Major group Chemicals And Allied Products | 208 out of 1,686 | 88th |
Industry group Drugs | 162 out of 1,365 | 88th |
Industry Pharmaceutical Preparations | 135 out of 1,043 | 87th |
Source: SEC filing on April 28, 2015.
Spiegel's colleagues
We found three more compensation records of executives who worked with Robert Spiegel at PTC Therapeutics in 2014.